2BB score and signals
Rocket Pharmaceuticals, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 67 | High |
| Momentum | 60 | Improving |
| Financial strength | 23 | Weak |
| Quality | 97 | Very Strong |
| Risk | 58 | Moderate |
Company facts
| Headquarters | Cranbury, New Jersey, United States |
| Founded | 1999 |
| Employees | 202 |
| 52-week range | $2.18 – $5.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.4174 | — | $680,003.00 |
| 2026-11-05 | — | -0.4123 | — | $459,000.00 |
| 2026-08-10 | -0.15 | 0.2467 | $0.00 | $20.40M |
| 2026-05-07 | -0.42 | -0.4151 | $0.00 | $0.00 |
Related companies